Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress

A legfontosabb adatok

Ki végzi
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Hol
Pittsburgh (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
3 fő vett részt
Kezdés
2021. aug. 4.
Befejezés
2025. márc. 1.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • nVNS
  • SOC
A regiszteradat frissítve
2026. május 29.

Ki vehet részt

Életkor
12 év – 80 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 20 feltétel megnézéseKevesebb

Ki vehet részt

  • Patient is between 12-80 years, inclusive
  • Patient has been admitted to the hospital for mild-to-moderate TBI that is restricted to the head and/or neck region
  • Patient is not on invasive mechanical ventilation
  • Patient has a mild-to-moderate TBI based on a non-resuscitated or post-resuscitated Glasgow Coma Scale (GCS) sum score of =>12
  • Patient has a Lung Injury Prediction Score (LIPS) of =>2
  • Administration of the first nVNS treatment must be planned to take place within 24 h of intake
  • A signed, written informed consent form from the patient or legally authorized representative

Ki nem vehet részt

  • Patient is receiving renal dialysis therapy for chronic renal failure
  • Patient is receiving extracorporeal membrane oxygenation, high-frequency oscillatory ventilation (HFOV) or any form of extracorporeal lung support
  • Patient has had any form of mechanical ventilation (invasive or non-invasive, excluding CPAP alone) for longer than 48 h prior to the diagnosis of mild-to-moderate respiratory distress/ARDS
  • Patient has an underlying clinical condition where, in the opinion of the study physicians and the institutional health provider physician, it would be extremely unlikely that the patient would not progress to invasive mechanical ventilation within 48 hours or any other condition that might require immediate invasive mechanical ventilation (e.g. motor neuron disease, Duchenne muscular dystrophy, or rapidly-progressive interstitial pulmonary fibrosis)
  • Patient has severe chronic obstructive pulmonary disease (COPD) requiring long-term home oxygen therapy or mechanical ventilation (non-invasive ventilation or via tracheotomy) except for continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BIPAP) used solely for sleep-disorder breathing
  • Patient has congestive heart failure
  • Patient has acute left ventricular failure
  • Patient has liver failure (Child-Pugh grade C)
  • Woman known to be pregnant, lactating or with a positive (urine or serum test) or indeterminate (serum test) pregnancy test
  • Patient has a diagnosis of moderate or greater grade of respiratory distress/ARDS according to the Berlin definition of ARDS: Partial pressure of oxygen (PaO2) /Fraction of Inspired Oxygen (FiO2) > 100 mmHg (>13.3 kPa) to ≤ 200 mmHg (≤ 26.6 kPa) with positive end-expiratory pressure (PEEP) ≥ 5 cmH2O)
  • Patient simultaneously taking part in another clinical trial
  • Patient is not expected to survive for 24 hours
  • Patient has burns to ≥ 15% of their total body surface area

Helyszínek itt: Egyesült Államok

  • AHN Allegheny General HospitalPittsburgh, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

This is a prospective, randomized, two-arm, controlled 30-day investigational pilot trial using the gammaCore Sapphire S non-invasive vagus nerve stimulation (nVNS) device + standard of care (SOC) in newly-hospitalized patients with mild-to-moderate traumatic brain injury (TBI) to prevent the progression towards immunokine storms, systemic inflammatory response syndrome (SIRS), severe respiratory distress, and requirement for invasive mechanical ventilation, and death, when compared to SOC alone (the control arm).

A vizsgálat 2 csoportja

  • Receiving Non-invasive vagus neurostimulationA vizsgált kezelés

    nVNS treatment will be applied three times daily. One treatment is defined as 2 consecutive stimulations: one, 2-minute stimulation on the side of the neck followed by a second, 2-minute stimulation on the same side of the neck. The treatment will be done 3 times per day (morning, mid-day and 1 hour before bed at night), every day, until patient is discharged from the hospital or requires mechanical ventilation. Patient will record the time they administered these treatments. If the patient is unable to do this, a research staff member who has been trained on the device can assist. Will also receive SOC for TBI.

    Kezelés: nVNS és SOC

  • Receiving Standard of CareEgyéb csoport

    Patients will be managed according to the institutional best practices and SOC for TBI.

    Kezelés: SOC

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Non-invasive Vagal Neurostimulation (nVNS) to Mitigate Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress and Acute Lung Injury
A regiszteradat frissítve
2026. május 29.